Nine Masts Capital »

Rani Therapeutics Hldgs shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $33k 45k 0.73

More positions owned by Nine Masts Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Alphabet Cap Stk Cl C (GOOG)
Warner Bros Discovery Com Ser A (WBD)
Silicon Laboratories (SLAB)
Hdfc Bank Sponsored Ads (HDB)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Norfolk Southern (NSC)
Clearwater Analytics Hldgs I Cl A (CWAN)
Webster Financial Corporation (WBS)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hologic
Nio Note 4.625%10/1 (Principal)
Ase Technology Hldg Sponsored Ads (ASX)

View all positions for Nine Masts Capital

Top funds holding Rani Therapeutics Hldgs

RA Capital Management
Samsara BioCapital
AWM Investment Company
Vanguard Group
Vanguard Capital Management
SymBiosis Capital Partners
Longaeva Partners
Susquehanna International
Siren
Geode Capital Management
BlackRock
Nan Fung Group Holdings
683 Capital Management
Vanguard Fiduciary Trust
Millennium Management

View all funds holding Rani Therapeutics Hldgs